Latest California Healthline Stories
Experts Tell Congress How To Cut Drug Prices. We Give You Some Odds.
Some of the nation’s most influential scientists recommend eight steps to lower drug prices. KHN takes the political temperature and tells you the chances of Congress acting on them.
An Overlooked Epidemic: Older Americans Taking Too Many Unneeded Drugs
Researchers estimate that 25 percent of people ages 65 to 69 take at least five prescription drugs to treat chronic conditions. But some doctors are trying to teach others about “deprescribing” or systematically discontinuing medicines that are inappropriate, duplicative or unnecessary.
Stopping Opioid Addiction At One Key Source: The Hospital
Based on research conducted at the University of Michigan’s medical center, a group of surgeons developed a strategy to help post-surgical patients from misusing or abusing their prescription painkillers.
Congress Isn’t Really Done With Health Care — Just Look At What’s In The Tax Bills
Even though congressional Republicans set aside their Obamacare repeal-and-replace efforts this year, here are five major health policy changes that could become law as part of the pending House and Senate proposals.
Podcast: ‘What The Health?’ Taxes, Medicare And The Year-End Mess
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post discuss the possible impact of the tax bill on the Medicare program, confirmation hearings for a new secretary of Health and Human Services and the future of the Children’s Health Insurance Program. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
Patients With Rare Diseases And Congress Square Off Over Orphan Drug Tax Credits
The House and Senate want to reduce or eliminate federal tax credits for “orphan drugs” used to treat rare diseases, but patients are fighting against the plan.
University Was Tipped Off To Possible Unauthorized Trials Of Herpes Vaccine
Southern Illinois University has concluded its researcher violated university rules and U.S. law.
The Ratcheting Price Of The Pneumococcal Vaccine: What Gives?
The price for Pfizer’s Prevnar 13 has increased 5 to 6 percent each year since its 2010 approval by the Food and Drug Administration.
Heated And Deep-Pocketed Battle Erupts Over 340B Drug Discount Program
Drugmakers, hospitals and lawmakers are taking sides in a showdown over a discount program that covers drug purchases at some hospitals.
Podcast: ‘What The Health?’ Meanwhile, In Other Health News…
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Sarah Jane Tribble of Kaiser Health News discuss some of the under-covered health stories of the past several weeks, including drug price issues, the opioid epidemic and women’s reproductive health.